Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 4/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | GMNN | O75496 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28007875 | 0.95 | ALDH1A1 (0.34) | ALDH1A1TSHRHPGDATMHCAR2 | |
| SCHEMBL28161237 | 0.95 | ALDH1A1 (0.34) | ALDH1A1TSHRHPGDATMHCAR2 | |
| SCHEMBL8593909 | 0.94 | NAAA (0.37) | ALDH1A1TSHRHCAR2MAPK1CYP3A4 | |
| Tert-Butyl Hydroperoxide SCHEMBL27986868 | 0.93 | TSHR (0.33) | ALDH1A1TSHRHPGDATMHCAR2 | |
| SCHEMBL28161238 | 0.93 | HCAR2 (0.35) | ALDH1A1TSHRHPGDATMHCAR2 | |
| SCHEMBL1581663 | 0.93 | NAAA (0.40) | ALDH1A1TSHRHCAR2TDP1TP53 | |
| Tert-Butyl Hydroperoxide SCHEMBL28255759 | 0.90 | HPGD (0.32) | ALDH1A1TSHRHPGDATMHCAR2 | |
| SCHEMBL131236 | 0.86 | ALDH1A1 (0.39) | ALDH1A1TSHRHPGDATMHCAR2 | |
| Acetophenone SCHEMBL28867202 | 0.85 | LMNA (0.42) | ALDH1A1TSHRHPGDTDP1L3MBTL1 | |
| Propiophenone SCHEMBL28262085 | 0.84 | SMN1; SMN2 (0.43) | ALDH1A1TSHRTDP1L3MBTL1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 284 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109890893-A | Fluoroelastomer composition | 索尔维特殊聚合物意大利有限公司 | 2019-06-14 | — | — | CN | claimed |
| CN-109863151-A | Fused tricyclic pyridazinone compounds for the treatment of orthomyxoviral infections | 诺华股份有限公司 | 2019-06-07 | — | — | CN | claimed |
| CN-109715718-A | Fluoroelastomer composition | 索尔维特殊聚合物意大利有限公司 | 2019-05-03 | — | — | CN | claimed |
| CN-106632483-A | Tenofovir disoproxil preparation method | 青岛辰达生物科技有限公司 | 2017-05-10 | — | — | CN | claimed |
| CN-106008603-A | Preparation methods of tenofovir disoproxil and fumarate thereof | 东北制药集团股份有限公司 | 2016-10-12 | — | — | CN | claimed |
| CN-104066775-B | Fibre-reinforced resin mold plastics and manufacture the method for fibre-reinforced molded resin by it | OCV INTELLECTUAL CAPITAL, LLC (US) | 2016-06-01 | — | — | CN | claimed |
| CN-102201563-B | Injection method of lithium ion battery electrolyte and the battery prepared | SHENZHEN BAK BATTERY CO., LTD. (CN) | 2016-02-10 | — | — | CN | claimed |
| CN-105283179-A | Novel analogues of epicatechin and related polyphenols | SPHAERA PHARMA PRIVATE LTD | 2016-01-27 | — | — | CN | claimed |
| US-7740826-B2 | Method for functionalizing carbon nanotubes utilizing peroxides | WILLIAM MARSH RICE UNIVERSITY (US) | 2010-06-22 | — | — | US | claimed |
| CN-101641353-A | Novel compounds for treatment of psychotic disorders, preparation methods and uses thereof | YOUXIN LI | 2010-02-03 | — | — | CN | claimed |
| US-20090306427-A1 | Chemical Functionalization of Carbon Nanotubes | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2009-12-10 | — | — | US | claimed |
| EP-1989143-A1 | CHEMICAL FUNCTIONALIZATION OF CARBON NANOTUBES | National Research Council of Canada (CA) | 2008-11-12 | — | — | EP | claimed |
| WO-2007098578-A1 | CHEMICAL FUNCTIONALIZATION OF CARBON NANOTUBES | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2007-09-07 | — | — | WO | claimed |
| US-20070098620-A1 | Method for functionalizing carbon nanotubes utilizing peroxides | WILLIAM MARSH RICE UNIVERSITY (US) | 2007-05-03 | — | — | US | claimed |
| WO-2006110305-A1 | PHOTOCHROMIC OPHTHALMIC DEVICES MADE WITH DUAL INITIATOR SYSTEM | JOHNSON & JOHNSON VISION CARE, INC. (US) | 2006-10-19 | — | — | WO | claimed |
| US-20040223900-A1 | Method for functionalizing carbon nanotubes utilizing peroxides | WILLIAM MARSH RICE UNIVERSITY (US) | 2004-11-11 | — | — | US | claimed |
| US-6432543-B1 | — | — | None | — | — | US | disclosed |
| US-20260117048-A1 | MODIFIER FOR POLYAMIDE RESINS AND POLYAMIDE RESIN COMPOSITION | KANEKA CORPORATION (JP) | 2026-04-30 | — | — | US | disclosed |
| US-3987019-A | ACRYLIC ESTER, PEROXIDE POLYMERIZATION CATALYST | HENKEL & CIE G.M.B.H. (DT) | 1976-10-19 | — | — | US | disclosed |
| US-3984385-A | ORGANIC SULFONIC ACID HYDRAZIDE | HENKEL & CIE G.M.B.H. (DT) | 1976-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260117048-A1 | MODIFIER FOR POLYAMIDE RESINS AND POLYAMIDE RESIN COMPOSITION | MEP1A, SMCHD1, SMC1A | ALDH1A1 1362/4885TSHR 4417/4885HPGD 2185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.